Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation

doi:doi:10.1172/JCI21748

dc.contributor.author	Freedman, Neil Jonathan
dc.contributor.author	Lefkowitz, Robert J.
dc.date.accessioned	2012-10-24T18:31:58Z
dc.date.available	2012-10-24T18:31:58Z
dc.date.issued	2004-05
dc.identifier.citation	Freedman, N. J. and R. J. Lefkowitz (2004). "Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation." The Journal of Clinical Investigation 113(10): 1379-1382.	en_US
dc.identifier.uri	http://hdl.handle.net/10161/5930
dc.description.abstract	Antibodies specific for the β1-adrenergic receptor are found in patients with chronic heart failure of various etiologies. From work presented in this issue of the JCI, we can now infer that these antibodies actually contribute to the pathogenesis of chronic heart failure. This commentary discusses mechanisms by which these antibodies may engender cardiomyopathy.	en_US
dc.publisher	American Society for Clinical Investigation	en_US
dc.relation.isversionof	doi:10.1172/JCI21748	en_US
dc.title	Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation	en_US
dc.type	Article	en_US
duke.description.endpage	1382	en_US
duke.description.issue	10	en_US
duke.description.startpage	1379	en_US
duke.description.volume	113	en_US
dc.relation.journal	Journal of Clinical Investigation	en_US